Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MICROVISION, INC.MVIS · Entity 1053 | Director | February 25, 2021 | March 01, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MICROVISION, INC.
Report date February 25, 2021 · Filed March 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2021-02-25 transaction · row 1
1 source rowRow 1 · 2021-02-25 · Disposition to issuer · Disposed 30,000 · Balance 30,000 F1: Shares were sold to satisfy an Israeli tax liability associated with previous vesting of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were sold to satisfy an Israeli tax liability associated with previous vesting of shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DarioHealth Corp.
Report date April 03, 2020 · Filed April 07, 2020
Section 16 reporting ended · disclosed 2020-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2020-04-03 transaction · row 1
1 source rowRow 1 · 2020-04-03 · Grant · Acquired 6,088 · Balance 20,000 F1: The reporting person was awarded 1,450 shares of common stock in exchange for waiving director fees owed for the first quarter of 2020 and 4,638 shares of common stock as a departure grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person was awarded 1,450 shares of common stock in exchange for waiving director fees owed for the first quarter of 2020 and 4,638 shares of common stock as a departure grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2021 Filed Mar 1, 2021 21:29 UTC | MICROVISION, INC. MVIS · Entity 1053 | Disposition to issuerCommon Stock | 30,000 | $16.36 | $490,710.00 |
DisclosureSEC source: 0001593968-21-000689 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Shares were sold to satisfy an Israeli tax liability associated with previous vesting of shares. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 23:13 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-000352 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · security: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. The reporting person did not receive a grant in 2020 at the time the other directors received their annual grants and instead is receiving a grant in early 2021. F1 · price: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. The reporting person did not receive a grant in 2020 at the time the other directors received their annual grants and instead is receiving a grant in early 2021. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 22:39 UTC | MICROVISION, INC. MVIS · Entity 1053 | Disposition to issuerCommon Stock | 67,289 | $2.60 | $174,951.40 |
DisclosureSEC source: 0001593968-20-002349 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Shares were sold to satisfy a tax liability associated with previous vesting of shares. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 20:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-044157 · tm2015091d7_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The reporting person was awarded 1,450 shares of common stock in exchange for waiving director fees owed for the first quarter of 2020 and 4,638 shares of common stock as a departure grant. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:15 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-021772 · tm207834-6_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,912 Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 21:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-008686 · tm206156d5_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,912 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2019. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 21:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076122 · tm1927375-6_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,462 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2019 in the aggregate amount of $6,250. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 21:58 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantCommon Stock | 27,289 | $0.73 | $20,000.11 |
DisclosureSEC source: 0001593968-19-002113 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,289 F1 · security: This stock grant was issued in lieu of the annual cash fee payable to the reporting person for service as an Independent Director of MicroVision, Inc. Read SEC document |
| July 09, 2019 Filed Jul 10, 2019 20:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 20,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-034302 · tv524965_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,211 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first and second quarters of 2019 in the aggregate amount of $12,500. Read SEC document |
| May 22, 2019 Filed May 23, 2019 22:42 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-19-001190 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · security: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. F1 · price: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 21:01 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 15,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-022457 · tv520225_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,379 Read SEC document |
| January 27, 2019 Filed Jan 29, 2019 21:03 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-003514 · tv511868_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,314 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2018 in the amount of $6,250. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 20:22 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-052748 · tv504215_form4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,064 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $6,250. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 21:15 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-18-001296 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · security: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. F1 · price: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. Read SEC document |
| July 09, 2018 Filed Jul 10, 2018 20:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037839 · tv498257_form4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,776 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2018 in the amount of $6,250. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 20:09 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 7,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-033552 · tv496168_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,484 Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 20:09 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-022378 · tv491866_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,362 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2018 in the amount of $6,250. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 21:18 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 3,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-001310 · tv482700_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,305 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $6,250. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 3,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-054093 · tv477605_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,322 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $6,250. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:03 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 2,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-036433 · v470573_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,955 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $6,250. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 20:19 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantCommon Stock | 10,000 | $1.95 | $19,500.00 |
DisclosureSEC source: 0001593968-17-000765 · primary_01.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · security: These shares represent restricted stock units. The reporting person vests ownership in the restricted stock units on the earlier of the day prior to the date of the Company's annual meeting of shareholders next following the date of grant, or one year from the date of grant, provided the reporting person continues to serve as a director on the vesting date. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 20:19 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 1,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-020714 · v464366_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,252 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $6,250. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 31,207 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001144204-17-005357 · v457883_4.xml · derivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,207 Underlying: Common Stock · 31,207 shares Expires 2023-01-30 F1 · derivative.exercise_date: The option vests in twelve equal quarterly installments commencing on January 30, 2017. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 21:44 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-002216 · v456902_4.xml · nonDerivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,544 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the months June to December of 2016 in the amount of $14,583.33. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 21:32 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001593968-16-001072 · primary_01.xml · derivative · entry 2 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: MicroVision Common Stock · 15,000 shares Expires 2026-09-29 Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 21:32 UTC | MICROVISION, INC. MVIS · Entity 1053 | GrantOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001593968-16-001072 · primary_01.xml · derivative · entry 1 Farhi Yalon · CIK 0001676128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: MicroVision Common Stock · 15,000 shares Expires 2026-09-29 F1 · security: The reporting person vests ownership in the stock option on the earlier of one year from the grant date or the day prior to the next regularly scheduled annual shareholders' meeting, subject to the terms of the 2013 Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.